About the Pistoia Alliance

Lowering Barriers to R&D Innovation

We are a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D.

Our projects transform R&D innovation through pre-competitive collaboration. We bring together the key constituents to identify the root causes that lead to R&D inefficiencies. We develop best practices and technology pilots to overcome common obstacles.

Our members collaborate as equals on open projects that generate significant value for the worldwide life sciences community.

Join the Pistoia Alliance today

The Pistoia Alliance is a group of life sciences industry experts. We use pre-competitive collaboration to address issues around aggregating, accessing, and sharing data that are essential to innovation, but provide little competitive advantage. We have a strong track record in delivering value from our projects, providing our membership with perspective on current problems, and being a source of impartial opinion. We were established in 2009 by representatives of AstraZeneca, GSK, Novartis and Pfizer who met at a conference in Pistoia, Italy.

Innovation in Action

By pooling resources from a number of companies we increase the efficiency of innovation. The projects that we deliver generate significant value and attain global adoption. We ensure our projects are as effective and valuable as possible by developing proven technological solutions that build on our high levels of knowledge and insight, and our ability to access the best researchers and scientists in the life sciences industry. We are a community of experts, and we openly publish our work for the benefit of the worldwide research community. 

Access our published resources

Operations Team

The Officers of the Pistoia Alliance work with volunteers and paid consultants to enact the strategy envisioned by the Pistoia Alliance Board of Directors. Our current Officers are:

Steve Arlington, President

Ashley George, GlaxoSmithKline, Treasurer

Martyn Wilkins, Company Secretary

Advisory Board

The Pistoia Alliance is advised by a panel of independent experts. Our current advisory board members are:

  • Alan Lewis (Board Director at Assembly Biosciences Inc., Board member at BıoMarın, President and CEO at Diavacs, Chairman of the Board at Batu Biologics, La Jolla, USA)
  • Bill Burns (Switzerland; Shire; Mesoblast; Vestergaard; Wellcome Trust; Institute of Cancer Research)
  • Bryn Roberts (Switzerland, Roche)
  • Carl Peck (USA, FDA and now NDAPartners)
  • David Feigel (USA, Amgen, UCSF and now NDA Partners)
  • Kevin Dean (UK, Cisco Europe, now Chair AMRA, Digital Health consultant & Adjunct Professor, Maersk Institute, Denmark)
  • Mike Farrar (UK, Head of NHS Trusts and now independent advisor, HC)
  • Paul Fitzpatrick (UK/USA, HLInc Consultant)
  • Shobie Ramakrishnan (USA, Genentech/AstraZeneca )
  • Tim Irish (UK, NICE, NED)
  • James P Sullivan (USA VP Discovery AbbVie)
  • Steve Wooding (UK/USA, Head Global Commercial and Market Access Strategy, Janssen)

Consultants

Our current consultants are:

  • Claire Bellamy, Perdiem Ltd.
  • Ian Harrow, Ian Harrow Consulting Ltd.
  • Richard Holland, New Forest Ventures Ltd.
  • Nick Lynch, Curlew Research Ltd.
  • Carmen Nitsche, CINforma Consulting
  • David Proudlock, Previse Consulting
  • Gabrielle Whittick, GMW Consulting
  • John Wise, Pharma Logistics Ltd.
  • Mary Beth Walsh, Kalleid Inc.
  • Gerhard Noelken, Data4Lab Ltd.
  • Paula de Matos, de Matos UX Consulting Ltd.
  • Richard Norman

Board of Directors

The Pistoia Board of Directors sets the overall strategic aims for the Alliance and includes representatives from Alliance member organizations. Current board members include:

Fiona Ford, DNAnexus

David Drake, AstraZeneca

Gene Tetreault, Dassault Systèmes

Christopher McKenna, Clarivate Analytics, formerly the IP&S business of Thomson Reuters

Jens Hoefkens, PerkinElmer

Alastair Binnie, BMS

Tim Hoctor, Elsevier

Richard Bolton, GlaxoSmithKline

Rob Brown, Dotmatics

Chris Waller, Merck & Co

Matt Jones, Tessella

Quan Yang, Novartis

Sergio H Rotstein, Pfizer

Michael Braxenthaler, Roche

Kees van Bochove, The Hyve

Paying Members

* Accenture
* Amgen
* AstraZeneca UK Limited
* Bayer Pharma AG
* Benchling
* Binocular Vision Advisors LLC
* Boehringer Ingelheim International GmBH
* Bristol-Myers Squibb
* ChemAxon Ltd
* Clarivate Analytics, formerly the IP&S business of Thomson Reuters
* Context Matters
* Copyright Clearance Center
* Dassault Systemes BIOVIA
* Databiology Ltd
* DNAnexus
* Dotmatics Limited
* Eagle Genomics Ltd.
* Elsevier Inc.
* F. Hoffmann-La Roche LTD (Roche)
* Glaxo Group Ltd.
* Infochem
* Insightomics
* Instem LSS Ltd
* Intomics
* Ionis Pharmaceuticals Inc. (were ISIS)
* IPQ Analytics LLC
* KNIME.com AG
* KWS SAAT SE
* Linguamatics Ltd
* Medexprim
* Merck & Co
* Merck KGaA
* Monocl Software
* Novartis Institutes for BioMedical Research, Inc.
* Novaseek Research
* Odysseus Data Services Inc
* Osthus GmbH
* PerkinElmer
* Pfizer, Inc.
* Pharmacelera
* Pine Biotech
* Promeditec srl
* Pryv SA
* quattro research GmbH
* Repositive
* SciBite
* Scitegrity Limited
* Shire
* Takeda Pharmaceutical Company Ltd (as subsidiary Millennium Pharma Inc.)
* Tessella
* The Hyve

Non-Paying Members

* Agrimetrics Ltd
* Alex M Clark
* Andy Zaayenga
* CCDC (Cambridge Crystallographic Data Centre)
* Chris Barber
* Christophe Jamain
* Daniel Taylor
* Edinburgh Parallel Computing Centre (EPCC)
* EMBL/EBI
* Gaia Paolini
* Ian Harrow
* IMGT®( ImMunoGeneTics)
* Inchi Trust
* Jan Holst Jenson
* Jaroslaw Tomczak
* John G. Sgouros
* Leah McEwen
* Lhasa Limited
* Louis Fisher
* Mike Furness
* Nick Trigg
* Nicola Fantini
* Paul Willer
* Peter Boogaard
* Peter Fields
* Philip Quinlan
* QFAB Bioinformatics
* Rachel Belani Baker
* Ricardo Grinberg-Funes
* Richard Hather
* Richard Lewin Wife
* Robert E. Schwartz
* Royal Society of Chemistry
* Rudy Potenzone
* SIB Swiss Institute of Bioinformatics
* Stuart Chalk
* Stuart Dollow
* Terry Stouch
* Tetsuo Shimamoto
* UCL- Peter Coveney Group
* University of Reading
* Wolfram Teetz
* Yannick Djoumbou Feunang

Governance

Interested parties may view our bylaws, our not for profit incorporation certificate, and our public financial returns.

Acknowledgements

Some images used on this website are courtesy of:

  • FreeDigitalPhotos.net: adamr, Archipoch, kjnnt.
  • OpenClipArt.org: Ryan Taylor.